Naproxen Sodium
NDC 62207-327, Naproxen Sodium, tablet, from Granules India Ltd.
- Product NDC
- 62207-327
- Status
- Listed
- Labeler
- Granules India Ltd
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA091353
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62207-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62207-327-41 | 62207032741 | 24 TABLET in 1 BOTTLE (62207-327-41) |
| 62207-327-42 | 62207032742 | 50 TABLET in 1 BOTTLE (62207-327-42) |
| 62207-327-43 | 62207032743 | 100 TABLET in 1 BOTTLE (62207-327-43) |
| 62207-327-47 | 62207032747 | 500 TABLET in 1 BOTTLE (62207-327-47) |
| 62207-327-49 | 62207032749 | 1000 TABLET in 1 BOTTLE (62207-327-49) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62207-327 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62207-327 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62207-327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.